About Us Services Careers FAQ Contact Us 0
Home Pharmaceuticals Paraganglioma Market Size to Grow by USD 3.12 billion by 2031
Paraganglioma Market

Paraganglioma Market Size, Share & Trends Analysis Report By Type (Sympathetic Paragangliomas, Parasympathetic Paragangliomas, Carotid Paragangliomas, Cervical Paragangliomas, Jugular Paragangliomas, Secretory Paragangliomas, Temporal Paragangliomas), By Treatment Type (Peptide Receptor Radionuclide Therapy, Surgery, Chemotherapy, Radiation Therapy, Others), By Therapeutic Drug (iobenguane I131, Cyclophosphamide, Vincristine, Dacarbazine), By End-User (Hospitals, Specialty Clinics, Cancer Research Institutes, Others) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2023-2031

Report Code: SRPH55568DR
Last Updated : Dec 04, 2023
Author : Straits Research
Starting From
USD 1850
Buy Now
File Formats

Market Segmentation

  1. Paraganglioma Market, By Type (2021-2031)
    1. Sympathetic Paragangliomas
    2. Parasympathetic Paragangliomas
    3. Carotid Paragangliomas
    4. Cervical Paragangliomas
    5. Jugular Paragangliomas
    6. Secretory Paragangliomas
    7. Temporal Paragangliomas
  2. Paraganglioma Market, By Treatment Type (2021-2031)
    1. Peptide Receptor Radionuclide Therapy
    2. Surgery
    3. Chemotherapy
    4. Radiation Therapy
    5. Others
  3. Paraganglioma Market, By Therapeutic Drug (2021-2031)
    1. iobenguane I131
    2. Cyclophosphamide
    3. Vincristine
    4. Dacarbazine
  4. Paraganglioma Market, By End-User (2021-2031)
    1. Hospitals
    2. Specialty Clinics
    3. Cancer Research Institutes
    4. Others
    1. North America
      1. North America Paraganglioma Market, By Type
        1. Sympathetic Paragangliomas
          1. Parasympathetic Paragangliomas
            1. Carotid Paragangliomas
              1. Cervical Paragangliomas
                1. Jugular Paragangliomas
                  1. Secretory Paragangliomas
                    1. Temporal Paragangliomas
                    2. North America Paraganglioma Market, By Treatment Type
                      1. Peptide Receptor Radionuclide Therapy
                        1. Surgery
                          1. Chemotherapy
                            1. Radiation Therapy
                              1. Others
                              2. North America Paraganglioma Market, By Therapeutic Drug
                                1. iobenguane I131
                                  1. Cyclophosphamide
                                    1. Vincristine
                                      1. Dacarbazine
                                      2. North America Paraganglioma Market, By End-User
                                        1. Hospitals
                                          1. Specialty Clinics
                                            1. Cancer Research Institutes
                                              1. Others
                                              2. U.S.
                                                1. U.S. Paraganglioma Market, By Type
                                                  1. Sympathetic Paragangliomas
                                                    1. Parasympathetic Paragangliomas
                                                      1. Carotid Paragangliomas
                                                        1. Cervical Paragangliomas
                                                          1. Jugular Paragangliomas
                                                            1. Secretory Paragangliomas
                                                              1. Temporal Paragangliomas
                                                              2. U.S. Paraganglioma Market, By Treatment Type
                                                                1. Peptide Receptor Radionuclide Therapy
                                                                  1. Surgery
                                                                    1. Chemotherapy
                                                                      1. Radiation Therapy
                                                                        1. Others
                                                                        2. U.S. Paraganglioma Market, By Therapeutic Drug
                                                                          1. iobenguane I131
                                                                            1. Cyclophosphamide
                                                                              1. Vincristine
                                                                                1. Dacarbazine
                                                                                2. U.S. Paraganglioma Market, By End-User
                                                                                  1. Hospitals
                                                                                    1. Specialty Clinics
                                                                                      1. Cancer Research Institutes
                                                                                        1. Others
                                                                                      2. Canada
                                                                                    2. Europe
                                                                                      1. Europe Paraganglioma Market, By Type
                                                                                        1. Sympathetic Paragangliomas
                                                                                          1. Parasympathetic Paragangliomas
                                                                                            1. Carotid Paragangliomas
                                                                                              1. Cervical Paragangliomas
                                                                                                1. Jugular Paragangliomas
                                                                                                  1. Secretory Paragangliomas
                                                                                                    1. Temporal Paragangliomas
                                                                                                    2. Europe Paraganglioma Market, By Treatment Type
                                                                                                      1. Peptide Receptor Radionuclide Therapy
                                                                                                        1. Surgery
                                                                                                          1. Chemotherapy
                                                                                                            1. Radiation Therapy
                                                                                                              1. Others
                                                                                                              2. Europe Paraganglioma Market, By Therapeutic Drug
                                                                                                                1. iobenguane I131
                                                                                                                  1. Cyclophosphamide
                                                                                                                    1. Vincristine
                                                                                                                      1. Dacarbazine
                                                                                                                      2. Europe Paraganglioma Market, By End-User
                                                                                                                        1. Hospitals
                                                                                                                          1. Specialty Clinics
                                                                                                                            1. Cancer Research Institutes
                                                                                                                              1. Others
                                                                                                                              2. U.K.
                                                                                                                                1. U.K. Paraganglioma Market, By Type
                                                                                                                                  1. Sympathetic Paragangliomas
                                                                                                                                    1. Parasympathetic Paragangliomas
                                                                                                                                      1. Carotid Paragangliomas
                                                                                                                                        1. Cervical Paragangliomas
                                                                                                                                          1. Jugular Paragangliomas
                                                                                                                                            1. Secretory Paragangliomas
                                                                                                                                              1. Temporal Paragangliomas
                                                                                                                                              2. U.K. Paraganglioma Market, By Treatment Type
                                                                                                                                                1. Peptide Receptor Radionuclide Therapy
                                                                                                                                                  1. Surgery
                                                                                                                                                    1. Chemotherapy
                                                                                                                                                      1. Radiation Therapy
                                                                                                                                                        1. Others
                                                                                                                                                        2. U.K. Paraganglioma Market, By Therapeutic Drug
                                                                                                                                                          1. iobenguane I131
                                                                                                                                                            1. Cyclophosphamide
                                                                                                                                                              1. Vincristine
                                                                                                                                                                1. Dacarbazine
                                                                                                                                                                2. U.K. Paraganglioma Market, By End-User
                                                                                                                                                                  1. Hospitals
                                                                                                                                                                    1. Specialty Clinics
                                                                                                                                                                      1. Cancer Research Institutes
                                                                                                                                                                        1. Others
                                                                                                                                                                      2. Germany
                                                                                                                                                                      3. France
                                                                                                                                                                      4. Spain
                                                                                                                                                                      5. Italy
                                                                                                                                                                      6. Russia
                                                                                                                                                                      7. Nordic
                                                                                                                                                                      8. Benelux
                                                                                                                                                                      9. Rest of Europe
                                                                                                                                                                    2. APAC
                                                                                                                                                                      1. APAC Paraganglioma Market, By Type
                                                                                                                                                                        1. Sympathetic Paragangliomas
                                                                                                                                                                          1. Parasympathetic Paragangliomas
                                                                                                                                                                            1. Carotid Paragangliomas
                                                                                                                                                                              1. Cervical Paragangliomas
                                                                                                                                                                                1. Jugular Paragangliomas
                                                                                                                                                                                  1. Secretory Paragangliomas
                                                                                                                                                                                    1. Temporal Paragangliomas
                                                                                                                                                                                    2. APAC Paraganglioma Market, By Treatment Type
                                                                                                                                                                                      1. Peptide Receptor Radionuclide Therapy
                                                                                                                                                                                        1. Surgery
                                                                                                                                                                                          1. Chemotherapy
                                                                                                                                                                                            1. Radiation Therapy
                                                                                                                                                                                              1. Others
                                                                                                                                                                                              2. APAC Paraganglioma Market, By Therapeutic Drug
                                                                                                                                                                                                1. iobenguane I131
                                                                                                                                                                                                  1. Cyclophosphamide
                                                                                                                                                                                                    1. Vincristine
                                                                                                                                                                                                      1. Dacarbazine
                                                                                                                                                                                                      2. APAC Paraganglioma Market, By End-User
                                                                                                                                                                                                        1. Hospitals
                                                                                                                                                                                                          1. Specialty Clinics
                                                                                                                                                                                                            1. Cancer Research Institutes
                                                                                                                                                                                                              1. Others
                                                                                                                                                                                                              2. China
                                                                                                                                                                                                                1. China Paraganglioma Market, By Type
                                                                                                                                                                                                                  1. Sympathetic Paragangliomas
                                                                                                                                                                                                                    1. Parasympathetic Paragangliomas
                                                                                                                                                                                                                      1. Carotid Paragangliomas
                                                                                                                                                                                                                        1. Cervical Paragangliomas
                                                                                                                                                                                                                          1. Jugular Paragangliomas
                                                                                                                                                                                                                            1. Secretory Paragangliomas
                                                                                                                                                                                                                              1. Temporal Paragangliomas
                                                                                                                                                                                                                              2. China Paraganglioma Market, By Treatment Type
                                                                                                                                                                                                                                1. Peptide Receptor Radionuclide Therapy
                                                                                                                                                                                                                                  1. Surgery
                                                                                                                                                                                                                                    1. Chemotherapy
                                                                                                                                                                                                                                      1. Radiation Therapy
                                                                                                                                                                                                                                        1. Others
                                                                                                                                                                                                                                        2. China Paraganglioma Market, By Therapeutic Drug
                                                                                                                                                                                                                                          1. iobenguane I131
                                                                                                                                                                                                                                            1. Cyclophosphamide
                                                                                                                                                                                                                                              1. Vincristine
                                                                                                                                                                                                                                                1. Dacarbazine
                                                                                                                                                                                                                                                2. China Paraganglioma Market, By End-User
                                                                                                                                                                                                                                                  1. Hospitals
                                                                                                                                                                                                                                                    1. Specialty Clinics
                                                                                                                                                                                                                                                      1. Cancer Research Institutes
                                                                                                                                                                                                                                                        1. Others
                                                                                                                                                                                                                                                      2. Korea
                                                                                                                                                                                                                                                      3. Japan
                                                                                                                                                                                                                                                      4. India
                                                                                                                                                                                                                                                      5. Australia
                                                                                                                                                                                                                                                      6. Singapore
                                                                                                                                                                                                                                                      7. Taiwan
                                                                                                                                                                                                                                                      8. South East Asia
                                                                                                                                                                                                                                                      9. Rest of Asia-Pacific
                                                                                                                                                                                                                                                    2. Middle East and Africa
                                                                                                                                                                                                                                                      1. Middle East and Africa Paraganglioma Market, By Type
                                                                                                                                                                                                                                                        1. Sympathetic Paragangliomas
                                                                                                                                                                                                                                                          1. Parasympathetic Paragangliomas
                                                                                                                                                                                                                                                            1. Carotid Paragangliomas
                                                                                                                                                                                                                                                              1. Cervical Paragangliomas
                                                                                                                                                                                                                                                                1. Jugular Paragangliomas
                                                                                                                                                                                                                                                                  1. Secretory Paragangliomas
                                                                                                                                                                                                                                                                    1. Temporal Paragangliomas
                                                                                                                                                                                                                                                                    2. Middle East and Africa Paraganglioma Market, By Treatment Type
                                                                                                                                                                                                                                                                      1. Peptide Receptor Radionuclide Therapy
                                                                                                                                                                                                                                                                        1. Surgery
                                                                                                                                                                                                                                                                          1. Chemotherapy
                                                                                                                                                                                                                                                                            1. Radiation Therapy
                                                                                                                                                                                                                                                                              1. Others
                                                                                                                                                                                                                                                                              2. Middle East and Africa Paraganglioma Market, By Therapeutic Drug
                                                                                                                                                                                                                                                                                1. iobenguane I131
                                                                                                                                                                                                                                                                                  1. Cyclophosphamide
                                                                                                                                                                                                                                                                                    1. Vincristine
                                                                                                                                                                                                                                                                                      1. Dacarbazine
                                                                                                                                                                                                                                                                                      2. Middle East and Africa Paraganglioma Market, By End-User
                                                                                                                                                                                                                                                                                        1. Hospitals
                                                                                                                                                                                                                                                                                          1. Specialty Clinics
                                                                                                                                                                                                                                                                                            1. Cancer Research Institutes
                                                                                                                                                                                                                                                                                              1. Others
                                                                                                                                                                                                                                                                                              2. UAE
                                                                                                                                                                                                                                                                                                1. UAE Paraganglioma Market, By Type
                                                                                                                                                                                                                                                                                                  1. Sympathetic Paragangliomas
                                                                                                                                                                                                                                                                                                    1. Parasympathetic Paragangliomas
                                                                                                                                                                                                                                                                                                      1. Carotid Paragangliomas
                                                                                                                                                                                                                                                                                                        1. Cervical Paragangliomas
                                                                                                                                                                                                                                                                                                          1. Jugular Paragangliomas
                                                                                                                                                                                                                                                                                                            1. Secretory Paragangliomas
                                                                                                                                                                                                                                                                                                              1. Temporal Paragangliomas
                                                                                                                                                                                                                                                                                                              2. UAE Paraganglioma Market, By Treatment Type
                                                                                                                                                                                                                                                                                                                1. Peptide Receptor Radionuclide Therapy
                                                                                                                                                                                                                                                                                                                  1. Surgery
                                                                                                                                                                                                                                                                                                                    1. Chemotherapy
                                                                                                                                                                                                                                                                                                                      1. Radiation Therapy
                                                                                                                                                                                                                                                                                                                        1. Others
                                                                                                                                                                                                                                                                                                                        2. UAE Paraganglioma Market, By Therapeutic Drug
                                                                                                                                                                                                                                                                                                                          1. iobenguane I131
                                                                                                                                                                                                                                                                                                                            1. Cyclophosphamide
                                                                                                                                                                                                                                                                                                                              1. Vincristine
                                                                                                                                                                                                                                                                                                                                1. Dacarbazine
                                                                                                                                                                                                                                                                                                                                2. UAE Paraganglioma Market, By End-User
                                                                                                                                                                                                                                                                                                                                  1. Hospitals
                                                                                                                                                                                                                                                                                                                                    1. Specialty Clinics
                                                                                                                                                                                                                                                                                                                                      1. Cancer Research Institutes
                                                                                                                                                                                                                                                                                                                                        1. Others
                                                                                                                                                                                                                                                                                                                                      2. Turkey
                                                                                                                                                                                                                                                                                                                                      3. Saudi Arabia
                                                                                                                                                                                                                                                                                                                                      4. South Africa
                                                                                                                                                                                                                                                                                                                                      5. Egypt
                                                                                                                                                                                                                                                                                                                                      6. Nigeria
                                                                                                                                                                                                                                                                                                                                      7. Rest of MEA
                                                                                                                                                                                                                                                                                                                                    2. LATAM
                                                                                                                                                                                                                                                                                                                                      1. LATAM Paraganglioma Market, By Type
                                                                                                                                                                                                                                                                                                                                        1. Sympathetic Paragangliomas
                                                                                                                                                                                                                                                                                                                                          1. Parasympathetic Paragangliomas
                                                                                                                                                                                                                                                                                                                                            1. Carotid Paragangliomas
                                                                                                                                                                                                                                                                                                                                              1. Cervical Paragangliomas
                                                                                                                                                                                                                                                                                                                                                1. Jugular Paragangliomas
                                                                                                                                                                                                                                                                                                                                                  1. Secretory Paragangliomas
                                                                                                                                                                                                                                                                                                                                                    1. Temporal Paragangliomas
                                                                                                                                                                                                                                                                                                                                                    2. LATAM Paraganglioma Market, By Treatment Type
                                                                                                                                                                                                                                                                                                                                                      1. Peptide Receptor Radionuclide Therapy
                                                                                                                                                                                                                                                                                                                                                        1. Surgery
                                                                                                                                                                                                                                                                                                                                                          1. Chemotherapy
                                                                                                                                                                                                                                                                                                                                                            1. Radiation Therapy
                                                                                                                                                                                                                                                                                                                                                              1. Others
                                                                                                                                                                                                                                                                                                                                                              2. LATAM Paraganglioma Market, By Therapeutic Drug
                                                                                                                                                                                                                                                                                                                                                                1. iobenguane I131
                                                                                                                                                                                                                                                                                                                                                                  1. Cyclophosphamide
                                                                                                                                                                                                                                                                                                                                                                    1. Vincristine
                                                                                                                                                                                                                                                                                                                                                                      1. Dacarbazine
                                                                                                                                                                                                                                                                                                                                                                      2. LATAM Paraganglioma Market, By End-User
                                                                                                                                                                                                                                                                                                                                                                        1. Hospitals
                                                                                                                                                                                                                                                                                                                                                                          1. Specialty Clinics
                                                                                                                                                                                                                                                                                                                                                                            1. Cancer Research Institutes
                                                                                                                                                                                                                                                                                                                                                                              1. Others
                                                                                                                                                                                                                                                                                                                                                                              2. Brazil
                                                                                                                                                                                                                                                                                                                                                                                1. Brazil Paraganglioma Market, By Type
                                                                                                                                                                                                                                                                                                                                                                                  1. Sympathetic Paragangliomas
                                                                                                                                                                                                                                                                                                                                                                                    1. Parasympathetic Paragangliomas
                                                                                                                                                                                                                                                                                                                                                                                      1. Carotid Paragangliomas
                                                                                                                                                                                                                                                                                                                                                                                        1. Cervical Paragangliomas
                                                                                                                                                                                                                                                                                                                                                                                          1. Jugular Paragangliomas
                                                                                                                                                                                                                                                                                                                                                                                            1. Secretory Paragangliomas
                                                                                                                                                                                                                                                                                                                                                                                              1. Temporal Paragangliomas
                                                                                                                                                                                                                                                                                                                                                                                              2. Brazil Paraganglioma Market, By Treatment Type
                                                                                                                                                                                                                                                                                                                                                                                                1. Peptide Receptor Radionuclide Therapy
                                                                                                                                                                                                                                                                                                                                                                                                  1. Surgery
                                                                                                                                                                                                                                                                                                                                                                                                    1. Chemotherapy
                                                                                                                                                                                                                                                                                                                                                                                                      1. Radiation Therapy
                                                                                                                                                                                                                                                                                                                                                                                                        1. Others
                                                                                                                                                                                                                                                                                                                                                                                                        2. Brazil Paraganglioma Market, By Therapeutic Drug
                                                                                                                                                                                                                                                                                                                                                                                                          1. iobenguane I131
                                                                                                                                                                                                                                                                                                                                                                                                            1. Cyclophosphamide
                                                                                                                                                                                                                                                                                                                                                                                                              1. Vincristine
                                                                                                                                                                                                                                                                                                                                                                                                                1. Dacarbazine
                                                                                                                                                                                                                                                                                                                                                                                                                2. Brazil Paraganglioma Market, By End-User
                                                                                                                                                                                                                                                                                                                                                                                                                  1. Hospitals
                                                                                                                                                                                                                                                                                                                                                                                                                    1. Specialty Clinics
                                                                                                                                                                                                                                                                                                                                                                                                                      1. Cancer Research Institutes
                                                                                                                                                                                                                                                                                                                                                                                                                        1. Others
                                                                                                                                                                                                                                                                                                                                                                                                                      2. Mexico
                                                                                                                                                                                                                                                                                                                                                                                                                      3. Argentina
                                                                                                                                                                                                                                                                                                                                                                                                                      4. Chile
                                                                                                                                                                                                                                                                                                                                                                                                                      5. Colombia
                                                                                                                                                                                                                                                                                                                                                                                                                      6. Rest of LATAM

                                                                                                                                                                                                                                                                                                                                                                                                                  Related Reports

                                                                                                                                                                                                                                                                                                                                                                                                                  Global Report
                                                                                                                                                                                                                                                                                                                                                                                                                  The global bispecific antibodies market size was valued at USD 8.2 billion in 2023 and is projected to reach a value of USD 224.6 billion by 2032, registering a CAGR of 44.4% during the forecast period (2024-2032). The rise in cancer incidence is a c
                                                                                                                                                                                                                                                                                                                                                                                                                  Buy Now
                                                                                                                                                                                                                                                                                                                                                                                                                  Global Report
                                                                                                                                                                                                                                                                                                                                                                                                                  The global X-Ray Inspection System Market size was valued at USD 734.5 Million in 2022 and is projected to reach USD 1231.3 Million by 2031, registering a CAGR of 6.6% during the forecast period (2023-2031). The rising awareness of the bene
                                                                                                                                                                                                                                                                                                                                                                                                                  Buy Now
                                                                                                                                                                                                                                                                                                                                                                                                                  Global Report
                                                                                                                                                                                                                                                                                                                                                                                                                  Inflight Catering Market Size and Trends The global inflight catering market size was valued at USD 13.62 billion in 2023. It is projected to reach from USD 15.16 billion in 2024 to USD 35.75 billion by 2032, growing at a CAGR of 11.32% during the f
                                                                                                                                                                                                                                                                                                                                                                                                                  Buy Now
                                                                                                                                                                                                                                                                                                                                                                                                                  Global Report
                                                                                                                                                                                                                                                                                                                                                                                                                  The global bladder scanners market size was valued at USD 141.70 million in 2022. It is projected to reach USD 232.38 million by 2031, growing at a CAGR of 5.65% during the forecast period (2023-2031). This is because many people globally have u
                                                                                                                                                                                                                                                                                                                                                                                                                  Buy Now
                                                                                                                                                                                                                                                                                                                                                                                                                  Global Report
                                                                                                                                                                                                                                                                                                                                                                                                                  The global hair removal wax market size was valued at USD 13,110 million in 2022. It is estimated to reach USD 20,228 million by 2031, growing at a CAGR of 4.9% during the forecast period (2023–2031). Highlights Soft wax
                                                                                                                                                                                                                                                                                                                                                                                                                  Buy Now

                                                                                                                                                                                                                                                                                                                                                                                                                  Purchase Benefits

                                                                                                                                                                                                                                                                                                                                                                                                                  • Eligible for a free updated report next year
                                                                                                                                                                                                                                                                                                                                                                                                                  • Completely customizable scope
                                                                                                                                                                                                                                                                                                                                                                                                                  • 30% discount on your next purchase
                                                                                                                                                                                                                                                                                                                                                                                                                  • Dedicated account manager
                                                                                                                                                                                                                                                                                                                                                                                                                  • Query resolution within 24 hours
                                                                                                                                                                                                                                                                                                                                                                                                                  • Permission to print the report

                                                                                                                                                                                                                                                                                                                                                                                                                  We are featured on :

                                                                                                                                                                                                                                                                                                                                                                                                                  www.straitsresearch.com
                                                                                                                                                                                                                                                                                                                                                                                                                  © Copyright . All rights Reserved.